Product Description

Neutropenia caused by cancer chemotherapy. Cancer patients receiving Myelosuppressive chemotherapy, especially after intensive bone marrow depriving chemotherapy. This product has shown to be safe and effective in reducing the incidence, degree and duration of neutropenia, in accelerating the recovery of absolute neutrophil count (ANC), and in decreasing the incidence of febrile neutropenia;